Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Episodes
Therapeutic Updates from the ADA 2026 Standards of Care
24 Dec 2025
Contributed by Lukas
Welcome back to Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives! In this episode, cohosts Diana Isaacs, PharmD, and Natal...
Orforglipron, Cagrilintide, and the Libre Assist
23 Dec 2025
Contributed by Lukas
Welcome back to Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives! In this episode of Diabetes Dialogue, cohosts Diana Isaac...
2026 Technology Updates and American Diabetes Association Standards of Care
17 Dec 2025
Contributed by Lukas
In this episode of Diabetes Dialogue, hosts Diana Isaacs, PharmD, an endocrine clinical pharmacist, director of Education and Training in Diabetes Tec...
Reacting to Retatrutide and TRIUMPH-4 Topline Data
17 Dec 2025
Contributed by Lukas
In this episode of Diabetes Dialogue, hosts Diana Isaacs, PharmD, an endocrine clinical pharmacist, director of Education and Training in Diabetes Tec...
Semaglutide Falls Short in Alzheimer Disease, Tirzepatide Shows Promise in T1D
25 Nov 2025
Contributed by Lukas
In this episode, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, breakdown recent trial news from the 2 most popular incretin therapies: semaglu...
Updates on Dexcom G7 and Semaglutide Pricing
21 Nov 2025
Contributed by Lukas
In this episode, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, review two major developments in diabetes care: the forthcoming 15-day Dexcom G...
Oral Semaglutide and SELECT at DTM 2025
29 Oct 2025
Contributed by Lukas
In this episode, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, meet in person at the Diabetes Technology Meeting (DTM) in San Francisco to dis...
Biolinq Shine, Insulin Icodec, and Eli Lilly's Pipeline
14 Oct 2025
Contributed by Lukas
Welcome back to Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives! In this episode, cohosts Diana Isaacs, PharmD, and Natali...
Celebrating 150 Episodes!
13 Oct 2025
Contributed by Lukas
In this milestone 150th episode of Diabetes Dialogue: Technology, Therapeutics, and Real-World Perspectives, hosts Diana Isaacs, PharmD, an endocrine ...
What's New at Medtronic Diabetes With Bob Vigersky, MD
02 Oct 2025
Contributed by Lukas
Welcome back to Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives! In this episode, cohosts Diana Isaacs, PharmD, and Natal...
Results of ATTAIN-1 and STEP UP Phase 3 Trials
25 Sep 2025
Contributed by Lukas
Welcome back to Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives! In this episode, cohosts Diana Isaacs, PharmD, an endocr...
Milestones for MiniMed 780G and Signos CGM for Weight Loss
07 Sep 2025
Contributed by Lukas
In this episode of Diabetes Dialogue: Technology, Therapeutics, and Real-World Perspectives, cohosts Diana Isaacs, PharmD, an endocrine clinical pharm...
Semaglutide & Tirzepatide Updates at ESC Congress 2025
05 Sep 2025
Contributed by Lukas
At ESC 2025, a pair of presentations highlighted the ongoing debate over cardiovascular risk reduction with semaglutide (Ozempic/Wegovy) and tirzepati...
FDA Approves Semaglutide (Wegovy) for MASH
22 Aug 2025
Contributed by Lukas
Welcome back to Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives! In this episode, cohosts Diana Isaacs, PharmD, an endocri...
ADCES 2025 Part 3 & Diabetes Tech Updates
22 Aug 2025
Contributed by Lukas
Welcome back to Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives! In this episode, Diana Isaacs, PharmD, an endocrine clin...
ADCES 2025 Recap Part 2
22 Aug 2025
Contributed by Lukas
Welcome back to Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives! In this episode, hosts Diana Isaacs, PharmD, an endocrine...
Orforglipron Topline Results & ADCES 2025 Part 1
19 Aug 2025
Contributed by Lukas
In this episode of Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, s...
Tirzepatide and SURPASS-CVOT Topline Results
05 Aug 2025
Contributed by Lukas
On July 31, 2025, Eli Lilly and Company announced topline data from the SURPASS‑CVOT trial comparing tirzepatide (Mounjaro) to dulaglutide (Trulicit...
Guideline Updates for Diabetes & Pregnancy
23 Jul 2025
Contributed by Lukas
Welcome back to Diabetes Dialogue: Technology, Therapeutics, and Real-World Perspectives! In this episode of Diabetes Dialogue, cohosts Diana Isaacs,...
GLP-1s, SGLT2s, and Diabetes Barbie at ENDO 2025
21 Jul 2025
Contributed by Lukas
Welcome back to Diabetes Dialogue: Technology, Therapeutics, and Real-World Perspectives! In this episode of Diabetes Dialogue, cohosts Diana Isaacs,...
Upcoming Research on Type 1 Diabetes in Pregnancy with Carol Levy, MD
18 Jul 2025
Contributed by Lukas
In this episode of Diabetes Dialogue, cohosts Diana Isaacs, PharmD, an endocrine clinical pharmacist, director of Education and Training in Diabetes T...
BELIEVE, GLP-1/GIP Agonists, and CATALYST Results at ADA 2025
16 Jul 2025
Contributed by Lukas
In this episode of Diabetes Dialogue, cohosts Diana Isaacs, PharmD, an endocrine clinical pharmacist, director of Education and Training in Diabetes T...
American Diabetes Association 2025 Trial Recap - Part 1
16 Jul 2025
Contributed by Lukas
In this episode of Diabetes Dialogue, cohosts Diana Isaacs, PharmD, an endocrine clinical pharmacist, director of Education and Training in Diabetes T...
The Diabetes Collective, with Rachael Sood, RN, MSN, APRN
24 Jun 2025
Contributed by Lukas
In this episode of Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives, recorded during the 85th Scientific Sessions of the Ame...
Addressing America's Shortage of Diabetes Care Providers, with Jay Shubrook, DO, & Conan Tu, MD
24 Jun 2025
Contributed by Lukas
In this episode of Diabetes Dialogue, recorded live at the 85th Scientific Sessions of the American Diabetes Association (ADA 2025), hosts Diana Isaac...
CATALYST Trial, Mifepristone, and Hypercortisolism in T2D, with John Buse, MD, PhD
23 Jun 2025
Contributed by Lukas
In this episode of Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, s...
Updates from Dexcom at ADA 2025, with Kevin Sayer
22 Jun 2025
Contributed by Lukas
In this special episode recorded at 85th Scientific Sessions of the American Diabetes Association (ADA 2025), hosts Diana Isaacs, PharmD, an endocrine...
REDEFINE 1 and REDEFINE 2, with Timothy Garvey, MD, and Melanie Davies, MD
22 Jun 2025
Contributed by Lukas
In this special episode recorded at 85th Scientific Sessions of the American Diabetes Association (ADA 2025), hosts Diana Isaacs, PharmD, an endocrine...
ADA 2025 Preview
11 Jun 2025
Contributed by Lukas
With a number of late-breaking presentations and high-profile phase 2 and 3 trials, the 2025 American Diabetes Association (ADA) Scientific Sessions r...
American Diabetes Association Consensus Report on MASLD
04 Jun 2025
Contributed by Lukas
In this episode of Diabetes Dialogue, cohostsDiana Isaacs, PharmD, an endocrine clinical pharmacist, director of Education and Training in Diabetes Te...
May 2025 Diabetes Tech & Breakthrough T1D Updates
02 Jun 2025
Contributed by Lukas
In this episode of Diabetes Dialogue, co-hosts hosts Diana Isaacs, PharmD, an endocrine clinical pharmacist, director of Education and Training in Dia...
INHALE-3 Trial and Afrezza, With Roy Beck, MD, PhD
28 May 2025
Contributed by Lukas
In this episode of Diabetes Dialogue, hosts Diana Isaacs, PharmD, an endocrine clinical pharmacist, director of Education and Training in Diabetes Tec...
Diabetes Dialogue: AACE 2025 Recap
26 May 2025
Contributed by Lukas
Video Version Only on HCPLive! In this episode of Diabetes Dialogue: Technology, Therapeutics, and Real-World Perspectives, co-hosts Diana Isaacs, P...
Real-World Impact of iLet Bionic Pancreas, With Steven Russell, MD, PhD
20 May 2025
Contributed by Lukas
Video Version Only on HCPLive! In this episode of Diabetes Dialogue, hosts Diana Isaacs, PharmD, an endocrine clinical pharmacist, director of Educa...
Luna Automated Insulin Delivery, With Jon Brilliant and John Sjölund
13 May 2025
Contributed by Lukas
Video Version Only on HCPLive! Key Episode Timestamps 00:00:05 Introduction and Background of Luna Diabetes 00:02:27 Overview of Luna and Its Uniqu...
Tirzepatide vs Semaglutide for Obesity, Understanding SURMOUNT-5
11 May 2025
Contributed by Lukas
Welcome back to Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives! Full results from the SURMOUNT-5 trial show tirzepatide (...
Diabetes Dialogue: Dexcom G7, Libre App, and Medtronic Simplera Sync
07 May 2025
Contributed by Lukas
Video Version Only on HCPLive! In this episode of Diabetes Dialogue: Technology, Therapeutics, and Real-World Perspectives, hosts Diana Isaacs, Ph...
Diabetes Dialogue: Semaglutide for MASH in ESSENCE Trial, With Arun Sanyal, MD
30 Apr 2025
Contributed by Lukas
Video Version Only on HCPLive! In this episode of Diabetes Dialogue: Technology, Therapeutics, and Real-World Perspectives, hosts Diana Isaacs, Phar...
Diabetes Dialogue: CATALYST Reveals High Prevalence of Hypercortisolism in T2D
29 Apr 2025
Contributed by Lukas
Video Version Only on HCPLive! In this episode of Diabetes Dialogue: Technology, Therapeutics, and Real-World Perspectives, hosts Diana Isaacs, Phar...
Diabetes Dialogue: Oral GLP-1 Orforglipron in ACHIEVE-1 Trial
24 Apr 2025
Contributed by Lukas
Video Version Only on HCPLive! In this episode of Diabetes Dialogue, hosts Diana Isaacs, PharmD, an endocrine clinical pharmacist, director of Educa...
SCORE, Semaglutide, and ACC Wrap-up
16 Apr 2025
Contributed by Lukas
In this episode, hosts Diana Isaacs, PharmD, an endocrine clinical pharmacist, director of Education and Training in Diabetes Technology, and co-direc...
Diabetes Dialogue: Screening for Presymptomatic T1D with Rifka Schulman-Rosenbaum, MD
15 Apr 2025
Contributed by Lukas
In this episode of Diabetes Dialogue, hosts Diana Isaacs, PharmD, an endocrine clinical pharmacist, director of Education and Training in Diabetes Tec...
Diabetes Dialogue: SOUL and STRIDE Trials from ACC 2025
09 Apr 2025
Contributed by Lukas
Video Version Only on HCPLive! In this episode, hosts Diana Isaacs, PharmD, an endocrine clinical pharmacist, director of Education and Training in ...
Diabetes Dialogue: Updates and News from ATTD 2025 Part 1
04 Apr 2025
Contributed by Lukas
Video Version Only on HCPLive! In this episode, hosts Diana Isaacs, PharmD, an endocrine clinical pharmacist, director of Education and Training in ...
Bionic Pancreas Brings AID to Primary Care & Telehealth
20 Mar 2025
Contributed by Lukas
In this episode of Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives, hosts Diana Isaacs, PharmD, an endocrine clinical pharm...
Diabetes Dialogue: Understanding Control-IQ+ AID Algorithm with Laurel Messer, PhD, RN
18 Mar 2025
Contributed by Lukas
Video Version Only on HCPLive! In this episode of Diabetes Dialogue, hosts Diana Isaacs, PharmD, an endocrine clinical pharmacist, director of Educa...
Impact of NovoCare Pharmacy, LillyDirect Self Pay on GLP-1 RA Access
16 Mar 2025
Contributed by Lukas
In this episode of Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives, hosts Diana Isaacs, PharmD, an endocrine clinical pharm...
1: News and Updates in Diabetes Care from February 2025
03 Mar 2025
Contributed by Lukas
In this episode of Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives, hosts Diana Isaacs, PharmD, an endocrine clinical pharm...
Omnipod 5 and Medtronic 780G for Type 2 Diabetes
15 Feb 2025
Contributed by Lukas
In this episode of Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives, hosts Diana Isaacs, PharmD, an endocrine clinical pharm...
Understanding Semaglutide (Ozempic) in CKD and T2D
31 Jan 2025
Contributed by Lukas
Welcome back to Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives! The US Food and Drug Administration (FDA) approval of se...
ADA’s 2025 Standards of Care in Diabetes Therapeutics
23 Jan 2025
Contributed by Lukas
Video Version Only on HCPLive! In this episode of Diabetes Dialogue: Technology, Therapeutics, and Real-World Perspectives, hosts Diana Isaacs, Phar...
ADA’s 2025 Standards of Care in Diabetes Technology
16 Jan 2025
Contributed by Lukas
Welcome back to Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives! Video Version only on HCPLive! In this episode of Diabet...
The Evolving Role of Registered Dietitian Nutritionists in Obesity
13 Jan 2025
Contributed by Lukas
In this episode of Diabetes Dialogue: Technology, Therapeutics, and Real-World Perspectives, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, are...
Leveraging Smart Algorithms for Insulin Optimization with Eran Atlas
06 Jan 2025
Contributed by Lukas
Video version only on HCPLive! In this episode of Diabetes Dialogue, hosts Diana Isaacs, PharmD, an endocrine clinical pharmacist, director of Educa...
Insights on INHALE-1 and CATALYST Trials
02 Jan 2025
Contributed by Lukas
Video Version only on HCPLive! In this episode of Diabetes Dialogue, hosts Diana Isaacs, PharmD, an endocrine clinical pharmacist, director of Edu...
Exploring New Horizons in Incretin Therapy for Diabetes and Weight Loss
22 Dec 2024
Contributed by Lukas
Video Version Only on HCPLive! In this episode, hosts Diana Isaacs, PharmD, an endocrine clinical pharmacist, director of Education and Training in ...
Diabetes Dialogue: Celebrating 2024 - The Year of the Continuous Glucose Monitor
16 Dec 2024
Contributed by Lukas
Welcome to this special edition of Diabetes Dialogue: Technology, Therapeutics, and Real-World Perspectives, hosted by Diana Isaacs, PharmD, an endocr...
Celebrating 25 Years of CGM, with Irl Hirsch, MD
15 Dec 2024
Contributed by Lukas
Video Version only on HCPLive! In celebration of the podcast surpassing 100 episodes, hosts Diana Isaacs, PharmD, an endocrine clinical pharmacist, ...
News and Updates in Diabetes at AHA 2024
21 Nov 2024
Contributed by Lukas
In this episode, hosts Diana Isaacs, PharmD, an endocrine clinical pharmacist, director of Education and Training in Diabetes Technology, and codirect...
Tirzepatide’s Long-Term Obesity Data
14 Nov 2024
Contributed by Lukas
In this episode, hosts Diana Isaacs, PharmD, an endocrine clinical pharmacist, director of Education and Training in Diabetes Technology, and codirect...
Latest Updates on Semaglutide
14 Nov 2024
Contributed by Lukas
Launched on November 14, 2024 to celebrate World Diabetes Day, this episode tackles a flurry of recent news and updates related to semaglutide (Ozempi...
Diabetes Tech Updates in October 2024
11 Nov 2024
Contributed by Lukas
This episode spotlights news in diabetes technology from the latter half of October 2024. In the episode, hosts breakdown updates from multiple compan...
What to Know About the Eversense 365 CGM, with Brian Hansen
16 Oct 2024
Contributed by Lukas
On September 17, 2024, Ascensia Diabetes Care and Senseonics announced the US Food and Drug Administration's (FDA) clearance of the Eversense 365 syst...
Lingo Availability & Embecta's Tubeless Patch Pump
11 Sep 2024
Contributed by Lukas
In this episode of Diabetes Dialogue: Technology, Therapeutics, and Real-World Perspectives, hosts Diana Isaacs, PharmD, an endocrine clinical pharmac...
Real-World Experience with Dexcom Stelo
11 Sep 2024
Contributed by Lukas
In this episode of Diabetes Dialogue: Technology, Therapeutics, and Real-World Perspectives, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, tak...
Sotagliflozin for T1D and Other ADCES Highlights
21 Aug 2024
Contributed by Lukas
This episode of Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives, our second related to the Association of Diabetes Care and...
First 10 Prices Announced from CMS Price Negotiations
19 Aug 2024
Contributed by Lukas
On August 15, 2024, the Biden-Harris Administration announced the price list for the first 10 drugs selected as part of the Medicare price negotiation...
Navigating ADCES 2024
19 Aug 2024
Contributed by Lukas
The Association of Diabetes Care and Education Specialists (ADCES) is an organization ahead of its time in the world of healthcare. Often, those in me...
SUMMIT and FINEARTS-HF, with Muthiah Vaduganathan, MD, MPH
10 Aug 2024
Contributed by Lukas
In this episode, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, welcome Muthiah Vaduganathan, MD, MPH, cardiologist and codirector of the Cen...
Simplera CGM and Medtronic's Partnership with Abbott
10 Aug 2024
Contributed by Lukas
In this episode of Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives, hosts Diana Isaacs, PharmD, an endocrine clinical pharm...
CATALYST Trial and Hypercortisolism in T2D, with John Buse, MD, PhD
02 Aug 2024
Contributed by Lukas
Even with the second half of the trial yet to be completed, results of the CATALYST trial have initiated a potentially seismic shift in discussions ar...
New Early-Stage T1D Monitoring Guidance, with Anastasia Albanese-O'Neill, PhD, APRN
18 Jul 2024
Contributed by Lukas
Less than a month after rebranding from JDRF to Breakthrough T1D, the leading type 1 diabetes advocacy organization has now released new consensus gui...
INHALE-3 and Diabetes Tech Updates, with Grazia Aleppo, MD
18 Jul 2024
Contributed by Lukas
At the 84th American Diabetes Association (ADA) Scientific Sessions, INHALE-3 was among the trials to take center stage. A phase 4 trial comparing the...
Blue Circle Health, with Monica Gomberg, MD
18 Jul 2024
Contributed by Lukas
Despite being a chronic autoimmune disease, the burden of type 1 diabetes is often overlooked in public health discussions. Not only are patients with...
Advances in AID and CGM at ADA 2024, with Davida Kruger, NP
18 Jul 2024
Contributed by Lukas
In this special edition episode from the 84th American Diabetes Association Scientific Sessions, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP,...
ADA Introduces Obesity Association, with Robert Gabbay, MD, PhD
18 Jul 2024
Contributed by Lukas
On the opening day of the 84th American Diabetes Association Scientific Sessions, the ADA ushered in a new era for their organization with the announc...
Patient Considerations for Inhaled Insulin, with Carol Levy, MD
18 Jul 2024
Contributed by Lukas
In this special edition recorded at the 84th American Diabetes Association Scientific Sessions, Carol Levy, MD, director of the Mount Sinai Diabetes ...
ADA 2024 Diabetes Technology Recap
18 Jul 2024
Contributed by Lukas
This special edition episode of Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives focuses on top highlights and updates in di...
June 2024 Updates in Diabetes Technology and T1D
17 Jun 2024
Contributed by Lukas
In this episode of Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, p...
GLAM and CRISTAL, Updates in Pregnancy
05 Jun 2024
Contributed by Lukas
In this episode, hosts provide their audience with an overview of a pair of new studies on the topic of diabetes in pregnancy: the GLAM and CRISTAL st...
FLOW Trial and Semaglutide's Benefit in Chronic Kidney Disease
31 May 2024
Contributed by Lukas
To celebrate the FLOW trial and break down what it means for people with type 2 diabetes and CKD, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP...
2024 ACP Type 2 Diabetes Recommendations
20 Apr 2024
Contributed by Lukas
The American College of Physicians has released new recommendations in favor of SGLT2i and GLP-1 RA and against the use of DPP-4i as second-line thera...
STEP HFpEF DM and Fair Allocation of Incretin-Based Therapies
20 Apr 2024
Contributed by Lukas
In this episode, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, tackle a pair of related topics: what the STEP HFpEF DM trial from ACC.24 mean...
What to Know about Sequel Med Tech's twiist AID System, with Alan Lotvin, MD
30 Mar 2024
Contributed by Lukas
The diabetes community welcomed an additional tool to the armamentarium with the US Food and Drug Administration’s clearance of the twiist automated...
Hot Topics and Updates from ATTD 2024
30 Mar 2024
Contributed by Lukas
In the third and final recap episode from the 17th annual International Conference on Advanced Technologies & Treatments for Diabetes, hosts of Di...
T1D Glycemic Improvement and CRISTAL at ATTD 2024
26 Mar 2024
Contributed by Lukas
In this episode, hosts provide insight from automated insulin delivery updates from the 17th annual International Conference on Advanced Technologies ...
FLOW Trial and Chronic Kidney Disease Updates, with Brendon Neuen, MBBS, PhD
22 Mar 2024
Contributed by Lukas
In this episode of Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives hosts are joined by Brendon Neuen, MBBS, PhD, nephrologi...
Dexcom Stelo and CGM Updates, with Jake Leach
22 Mar 2024
Contributed by Lukas
Hosts of Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives recorded a special edition episode with Jake Leach, chief operatin...
Tirzepatide and the Future of Incretin Therapies, with Timothy Garvey, MD
18 Mar 2024
Contributed by Lukas
W. Timothy Garvey, MD, professor of medicine and director of the Diabetes Research Center at the University of Alabama at Birmingham and the principal...
SELECT, Semaglutide, & the Future of Incretin Therapies, with A. Michael Lincoff, MD
02 Mar 2024
Contributed by Lukas
In this episode, hosts are joined by co-chair of the SELECT steering committee A. Michael Lincoff, MD, to discuss results, potential explanations for ...
Understanding MARD, Comparing Popular CGM Sensors
29 Feb 2024
Contributed by Lukas
In this episode, the hosts breakdown a pair of recent publications related to better understanding the strengths and limitations of MARD as well as a ...
ATTD 2024 Preview
26 Feb 2024
Contributed by Lukas
In the episode, hosts provide insight into sessions to watch, device news they are excited for, what makes ATTD a unique and valuable experience for t...
Time in Range, CGM Metrics for Predicting Outcomes in Diabetes
20 Feb 2024
Contributed by Lukas
The introduction of CGM in 1999 completely shifted the trajectory of care for people with diabetes. Now, new data suggest advanced CGM metrics, such a...
Tirzepatide in Type 1 Diabetes, with Viral Shah, MD
15 Feb 2024
Contributed by Lukas
In this episode, hosts are joined by Shah for a discussion on his recent proof-of-concept study looking at tirzepatide in type 1 diabetes, the prospec...
Diabetes Technology Updates in January 2024
10 Jan 2024
Contributed by Lukas
In this episode, hosts discuss recent news and updates in diabetes technology from Abbott, Dexcom, and Medtronic in the first half of January 2024. E...
Updates in Management of Hypercortisolism in Type 2 Diabetes, with Ralph DeFronzo, MD
09 Jan 2024
Contributed by Lukas
In this episode, hosts sit down with Ralph DeFronzo, MD, for a discussion on how advances in management have transformed the diagnosis and management ...
Latest Updates on Diabetes Management in Pregnancy
08 Jan 2024
Contributed by Lukas
In this episode, the hosts break down a pair of recent studies published in JAMA examining use of non-insulin agents in the management of diabetes dur...
Baricitinib & the Potential Disease-Modifying Therapies in Type 1 Diabetes
03 Jan 2024
Contributed by Lukas
Hosts discuss a recent study on baricitinib in type 1 diabetes, how these results compare to other data in this arena, and what all of these studies m...
Diabetes Dialogue: 2023 Top Episodes Recap
01 Jan 2024
Contributed by Lukas
To celebrate the end of 2023, hosts recap the top 10 episodes of the past year and offer perspective on how the news discussed in these episodes has s...
Key Updates in ADA Standards of Care—2024
29 Dec 2023
Contributed by Lukas
Hosts discuss what they consider the most significant or relevant updates in the ADA's Standards of Care—2024, with a focus on new recommendations f...